SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about disclosures

20 Jun 2026 Evaluate
Zydus Lifesciences has enclosed disclosures in prescribed Form ‘C’ under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, received from Promoters, Promoters Group, Directors and their immediate relatives with respect to acceptance of Equity Shares of Re 1 each of the Company tendered under buyback through tender offer on proportionate basis.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1069.75 -1.15 (-0.11%)
22-Jun-2026 10:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.75
Dr. Reddys Lab 1283.75
Cipla 1402.20
Zydus Lifesciences 1069.75
Lupin 2351.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: